Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for CNI Toxicity in Kidney Transplant
NCT01021943Phase 2Suspended
- Sponsor
- Instituto Nacional de Cardiología Ignacio Chávez
- Start
- Nov 2009
- Countries
- 1
01
Overview
A Phase 2 trial of spironolactone in nephrotoxicity, sponsored by Instituto Nacional de Cardiología Ignacio Chávez. Started Nov 2009; status: suspended.
02
Drugs
spironolactone
03
Conditions
nephrotoxicity
Beyond the preview
Go deeper on NCT01021943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01021943.